MyAverix Finance
F · Healthcare
Adlai Nortye Ltd. (N2U0)
Biotechnology
Adlai Nortye Ltd. (N2U0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $331.88M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for N2U0
Adlai Nortye Ltd. (N2U0) — FAQ
What is Adlai Nortye Ltd.'s market cap?
Adlai Nortye Ltd. (N2U0) has a reported market cap of $331.88M (data as of 2026-03-30).
What is N2U0's P/E ratio?
The price-to-earnings (P/E) ratio for Adlai Nortye Ltd. (N2U0) is 18.00 (data as of 2026-03-30).
Does Adlai Nortye Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Adlai Nortye Ltd. (N2U0). Check the MyAverix Finance app for the latest dividend data.
What sector is Adlai Nortye Ltd. in?
Adlai Nortye Ltd. (N2U0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is N2U0 listed on?
N2U0 is listed on F.
What is Adlai Nortye Ltd.'s net margin?
Adlai Nortye Ltd. (N2U0) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.